Patents by Inventor Jeffrey R. Gardner

Jeffrey R. Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF
    Publication number: 20220275017
    Abstract: Truncated triterpene saponin analogues containing a trisaccharide or tetrasaccharide ester are disclosed. Also disclosed are pharmaceutical compositions comprising truncated saponin analogues and synthetic methods of producing the truncated saponin analogues. Another aspect of the present application relates to a method for immunizing a subject, comprising administering to the subject the pharmaceutical composition comprising a minimal saponin analogue and an antigen.
    Type: Application
    Filed: March 14, 2022
    Publication date: September 1, 2022
    Inventors: David Y. GIN, Eric K. CHEA, Alberto FERNANDEZ-TEJADA, Derek S. TAN, Jason S. LEWIS, Jeffrey R. GARDNER, NagaVaraKishore PILLARSETTY
  • Minimal saponin analogues, synthesis and use thereof
    Patent number: 11274116
    Abstract: Truncated triterpene saponin analogues containing a trisaccharide or tetrasaccharide ester are disclosed. Also disclosed are pharmaceutical compositions comprising truncated saponin analogues and synthetic methods of producing the truncated saponin analogues. Another aspect of the present application relates to a method for immunizing a subject, comprising administering to the subject the pharmaceutical composition comprising a minimal saponin analogue and an antigen.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: March 15, 2022
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: David Y. Gin, Eric K. Chea, Alberto Fernandez-Tejada, Derek S. Tan, Jason S. Lewis, Jeffrey R. Gardner, NagaVarakishore Pillarsetty
  • Dosage Regimen for the Treatment of Multiple Sclerosis with a S1P Receptor Modulator
    Publication number: 20210338635
    Abstract: The present application relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from an inflammatory or autoimmune disease or disorder, for example multiple sclerosis (MS).
    Type: Application
    Filed: July 16, 2021
    Publication date: November 4, 2021
    Inventor: Jeffrey R. GARDNER
  • Dosage regimen of an S1P receptor modulator
    Patent number: 11135197
    Abstract: The present application relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from an inflammatory or autoimmune disease or disorder, for example multiple sclerosis (MS).
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: October 5, 2021
    Assignee: Argentum Pharmaceuticals LLC
    Inventor: Jeffrey R. Gardner
  • Dosage Regimen of an S1P Receptor Modulator
    Publication number: 20210244708
    Abstract: The present application relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from an inflammatory or autoimmune disease or disorder, for example multiple sclerosis (MS).
    Type: Application
    Filed: February 5, 2021
    Publication date: August 12, 2021
    Inventor: Jeffrey R. GARDNER
  • MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF
    Publication number: 20210070796
    Abstract: Truncated triterpene saponin analogues containing a trisaccharide or tetrasaccharide ester are disclosed. Also disclosed are pharmaceutical compositions comprising truncated saponin analogues and synthetic methods of producing the truncated saponin analogues. Another aspect of the present application relates to a method for immunizing a subject, comprising administering to the subject the pharmaceutical composition comprising a minimal saponin analogue and an antigen.
    Type: Application
    Filed: April 20, 2020
    Publication date: March 11, 2021
    Inventors: David Y. Gin, Eric K. Chea, Alberto Fernandez-Tejada, Derek S. Tan, Jason S. Lewis, Jeffrey R. Gardner, NagaVaraKishore Pillarsetty
  • Minimal saponin analogues, synthesis and use thereof
    Patent number: 10626137
    Abstract: Truncated triterpene saponin analogues containing a trisaccharide or tetrasaccharide ester are disclosed. Also disclosed are pharmaceutical compositions comprising truncated saponin analogues and synthetic methods of producing the truncated saponin analogues. Another aspect of the present application relates to a method for immunizing a subject, comprising administering to the subject the pharmaceutical composition comprising a minimal saponin analogue and an antigen.
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: April 21, 2020
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: David Y. Gin, Eric K. Chea, Alberto Fernandez-Tejada, Derek S. Tan, Jason S. Lewis, Jeffrey R. Gardner, NagaVaraKishore Pillarsetty
  • MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF
    Publication number: 20170096444
    Abstract: Truncated triterpene saponin analogues containing a trisaccharide or tetrasaccharide ester are disclosed. Also disclosed are pharmaceutical compositions comprising truncated saponin analogues and synthetic methods of producing the truncated saponin analogues. Another aspect of the present application relates to a method for immunizing a subject, comprising administering to the subject the pharmaceutical composition comprising a minimal saponin analogue and an antigen.
    Type: Application
    Filed: June 1, 2015
    Publication date: April 6, 2017
    Inventors: David Y. GIN, Eric K. CHEA, Alberto FERNANDEZ-TEJADA, Derek S. TAN, Jason S. LEWIS, Jeffrey R. GARDNER, NagaVarakishore PILLARSETTY
  • Communication system for delivering sterilization test results to customers
    Publication number: 20020099572
    Abstract: A communication system includes a central unit, at least one customer unit and a communication link between the central and customer units. The central unit is provided with a server computer operative to have a first mode of communication, wherein sterilizer test results are provided during communication initiated by the one customer unit, and a second mode of communication, wherein the sterilizer test results are provided during communication initiated by the central unit.
    Type: Application
    Filed: September 24, 2001
    Publication date: July 25, 2002
    Inventors: John D. Dyckman, Jeffrey R. Gardner, Robert R. Jenks